Research advances toward more effective, long-lasting and side effect-free cancer treatments
The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read More
The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read MoreFrom the Labs sat with Dr. Rishabh Lohray, a first-year dermatology resident, to learn about his experiences as a member of the research team and a little about him.
Read MoreDr. Shanda Blackmon explains lung cancer, including symptoms to be aware of, how it is contracted and the treatment options available.
Read MoreThe next step could include human clinical trials to test potential therapeutic avenues to restore the ability to fight the tumor.
Read MoreThoracic surgeons share their insights on lung cancer, including causes, symptoms, latest treatments and the importance of screening.
Read MoreDr. Shanda Blackmon discusses pulmonary segmentectomy, a surgery used to treat lung cancer by removing a segment (or segments) of the lung.
Read MoreThis study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreResearchers at Baylor College of Medicine discover how airborne ultrafine particles in smoke can change a host’s defense against lung cancer.
Read MoreNew research is completely changing the way surgeons operate on patients with lung cancer. Dr. Ramiro Fernandez explains how this will help patients.
Read MoreThis study revealed five new susceptibility genes, 10 new variant associations from known risk genes and further validated in different populations another 24 associations.
Read More